Management Team
Dane Andreeff is Chief Executive Officer of Myocardial Solutions. At Myocardial Solutions, Dane is focused on bringing MyoStrain to more patients by expanding its clinical use in the United States, broadening support across MRI platforms, and advancing innovation in cardiac MRI. Dane has led and invested in medical technology companies for many years. Before joining Myocardial Solutions, he served as President, Chief Executive Officer and Director of Helius Medical Technologies, Inc., a medical device company focused on improving neurological health and wellness.
He also served for 13 years on the board of HDL Therapeutics, which developed the first FDA-cleared therapy of its kind to rapidly reverse coronary atherosclerosis in patients with homozygous familial hypercholesterolemia (HoFH). Dane founded Maple Leaf Partners, LLC and Andreeff Equity Advisors, LP.
With over 18 years of global experience leading and transforming teams across Biotech, Pharma and Medical Devices, Rafael Rivero, MD leads the initiative in expanding MyoStrain clinical utilization and advocacy within the medical community. Dr. Rivero received his MD at the Superior School of Medicine in Cuba in 1992 and his professional experience includes Monogram Biosciences, Gilead Sciences, Abbott Laboratories, Stereotaxis and Ortho Clinical Diagnostics.
Clete has over 35 years of experience in healthcare operational and business development leadership roles. Clete previously served as President of Outpatient Imaging and Joint Ventures at US Radiology, a WCAS privately-equity backed platform, President of Touchstone Medical Imaging, a national outpatient imaging operator acquired by US Radiology, Chief Development Officer of RadNet, and a Healthcare Partner and National Industry Director for KPMG. He most recently was the CEO of Pacesetter Health. Clete is a Board Member of Medisend College of Biomedical Engineering which is a premier educational center for training US veterans in biomedical engineering technology as well as The Warren Center, which advocates, serves, and empowers children and their families impacted by development delays and disabilities. Clete graduated from the University of Texas at Austin with high honors with a BBA in Accounting.
Nael Osman founded Myocardial Solutions after developing MyoStrain’s technology as a professor at Johns Hopkins University. As a known leader in cardiac MRI technology, Nael has pushed the frontiers of measuring regional function of the heart using MRI. Nael is an accomplished researcher and academician with a track record of academic publications (60+ scientific papers, 100+ conference presentations and abstracts), research contribution, teaching and life science innovation.
Jim Whayne joined Myocardial Solutions to direct clinical initiatives. He has 25 years of medical device and entrepreneurial experience, having cofounded 3 device companies – nContact, Cayenne Medical and Converge Medical. Mr. Whayne holds a Master of Science in Biomedical Engineering from the University of Virginia and a Bachelor Degree in Biomedical and Electrical Engineering from Duke University. He is also an inventor on over 200 issued US patents.
Sidney Fleischman has 25 years of experience in bringing medical devices from concept to commercialization. He has cofounded several successful medical device companies, including nContact, Cayenne Medical, and Converge Medical. He holds a BS in Mechanical Engineering from UC Santa Barbara and is an inventor of more than 100 issued patents in the medical device area.